SIRT5 and precursor B-cell acute lymphoblastic leukemia: This result was further confirmed by identifying an increase in SIRT5 levels in the bone marrow-derived from xenografted mice (Fig. 4D) and patients with primary B-ALL (Fig. 4E and S4B) in the combined treatment group compared to other groups.